These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20605346)

  • 1. Tumor volume is a prognostic factor in non-small-cell lung cancer treated with chemoradiotherapy.
    Alexander BM; Othus M; Caglar HB; Allen AM
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1381-7. PubMed ID: 20605346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline cardiopulmonary function as an independent prognostic factor for survival of inoperable non-small-cell lung cancer after concurrent chemoradiotherapy: a single-center analysis of 161 cases.
    Semrau S; Klautke G; Fietkau R
    Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):96-104. PubMed ID: 20350789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors for survival in stage III non-small-cell lung cancer treated with definitive radiation therapy: impact of tumor volume.
    Basaki K; Abe Y; Aoki M; Kondo H; Hatayama Y; Nakaji S
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):449-54. PubMed ID: 16226400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a prognostic model using blood biomarker information for prediction of survival of non-small-cell lung cancer patients treated with combined chemotherapy and radiation or radiotherapy alone (NCT00181519, NCT00573040, and NCT00572325).
    Dehing-Oberije C; Aerts H; Yu S; De Ruysscher D; Menheere P; Hilvo M; van der Weide H; Rao B; Lambin P
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):360-8. PubMed ID: 20888135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a treatment strategy for optimising preoperative chemoradiotherapy in stage III non-small-cell lung cancer.
    Phernambucq EC; Spoelstra FO; Paul MA; Senan S; Melissant CF; Postmus PE; Smit EF
    Eur J Cardiothorac Surg; 2009 Dec; 36(6):1052-7. PubMed ID: 19616442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study.
    Baldini E; Silvano G; Tibaldi C; Campoccia S; Cionini L; Conte P
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):28-32. PubMed ID: 10697041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Age-related prognostic factors and treatment results for advanced non-small cell lung cancer (NSCLC)].
    Clement D; Miron L; Marinca M
    Rev Med Chir Soc Med Nat Iasi; 2007; 111(4):856-63. PubMed ID: 18389770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and external validation of prognostic model for 2-year survival of non-small-cell lung cancer patients treated with chemoradiotherapy.
    Dehing-Oberije C; Yu S; De Ruysscher D; Meersschout S; Van Beek K; Lievens Y; Van Meerbeeck J; De Neve W; Rao B; van der Weide H; Lambin P
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):355-62. PubMed ID: 19095367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High radiation dose may reduce the negative effect of large gross tumor volume in patients with medically inoperable early-stage non-small cell lung cancer.
    Zhao L; West BT; Hayman JA; Lyons S; Cease K; Kong FM
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):103-10. PubMed ID: 17363189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Phase II study of synchronous three-dimensional conformal boost to the gross tumor volume for patients with unresectable Stage III non-small-cell lung cancer: results of Korean Radiation Oncology Group 0301 study.
    Cho KH; Ahn SJ; Pyo HR; Kim KS; Kim YC; Moon SH; Han JY; Kim HT; Koom WS; Lee JS
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1397-404. PubMed ID: 19117690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does response to induction chemotherapy predict survival for locally advanced non-small-cell lung cancer? Secondary analysis of RTOG 8804/8808.
    McAleer MF; Moughan J; Byhardt RW; Cox JD; Sause WT; Komaki R
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):802-8. PubMed ID: 19540055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-chemotherapy gross tumor volume is predictive of survival in patients with stage III non-small cell lung cancer treated with combined modality therapy.
    Stinchcombe TE; Morris DE; Moore DT; Bechtel JH; Halle JS; Mears A; Deschesne K; Rosenman JG; Socinski MA
    Lung Cancer; 2006 Apr; 52(1):67-74. PubMed ID: 16499996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment-related pneumonitis and acute esophagitis in non-small-cell lung cancer patients treated with chemotherapy and helical tomotherapy.
    Song CH; Pyo H; Moon SH; Kim TH; Kim DW; Cho KH
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):651-8. PubMed ID: 20207499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of different chemotherapy regimens for concurrent chemoradiotherapy on locally advanced non-small cell lung cancer].
    Ren H; Wang LH; Wang XZ; Lü JM; Ji W; Zhou ZM; Ou GF; Yin WB
    Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):143-7. PubMed ID: 19538894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognosis of locally advanced non small cell lung cancer treated with three dimentional conformal radiotherapy].
    Zhu XZ; Wang LH; Ou GF; Zhou ZM; Chen DF; Xiao ZF; Feng QF; Zhang HX; Wang M; Yin WB
    Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):748-53. PubMed ID: 18396686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radiochemotherapy of non-small-cell bronchial carcinoma. A report of experience].
    Müller G; Kiricuta IC; Stiess J; Flentje M
    Strahlenther Onkol; 1996 Aug; 172(8):446-54. PubMed ID: 8765348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoradiotherapy for poor-risk stage III non-small cell lung cancer.
    Lau DH; Ryu JK; Gandara DR
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-110-S12-112. PubMed ID: 9331133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omission of elective node irradiation on basis of CT-scans in patients with limited disease small cell lung cancer: a phase II trial.
    De Ruysscher D; Bremer RH; Koppe F; Wanders S; van Haren E; Hochstenbag M; Geeraedts W; Pitz C; Simons J; ten Velde G; Dohmen J; Snoep G; Boersma L; Verschueren T; van Baardwijk A; Dehing C; Pijls M; Minken A; Lambin P
    Radiother Oncol; 2006 Sep; 80(3):307-12. PubMed ID: 16949169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose conformal radiotherapy for patients with stage III non-small-cell lung carcinoma.
    Nakayama H; Satoh H; Kurishima K; Ishikawa H; Tokuuye K
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):645-50. PubMed ID: 20869582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of acute esophagitis in lung cancer patients treated with concurrent three-dimensional conformal radiotherapy and chemotherapy.
    Rodríguez N; Algara M; Foro P; Lacruz M; Reig A; Membrive I; Lozano J; López JL; Quera J; Fernández-Velilla E; Sanz X
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):810-7. PubMed ID: 18755556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.